Versant Capital Management’s Select Medical SEM Stock Holding History

Versant Capital Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.6K	Hold	1,915	–	–	﹤0.01%	1684
2026 Q1	$31.2K	Buy	1,915 +31	+2%	+$485	﹤0.01%	1544
2025 Q4	$28K	Buy	1,884 +108	+6%	+$1.53K	﹤0.01%	1432
2025 Q3	$22.8K	Buy	1,776 +920	+107%	+$12.3K	﹤0.01%	1516
2025 Q2	$13K	Buy	856 +25	+3%	+$390	﹤0.01%	1764
2025 Q1	$13.9K	Hold	831	–	–	﹤0.01%	1539
2024 Q4	$15.7K	Sell	831 -865	-51%	-$16.7K	﹤0.01%	1152
2024 Q3	$31.9K	Hold	1,696	–	–	0.01%	611
2024 Q2	$32K	Hold	1,696	–	–	0.01%	549
2024 Q1	$27.6K	Hold	1,696	–	–	0.01%	405
2023 Q4	$21.5K	Sell	1,696 -737	-30%	-$9.3K	0.01%	467
2023 Q3	$33.1K	Sell	2,433 -9	-0.4%	-$139	0.01%	354
2023 Q2	$41.9K	Buy	2,442 +9	+0.4%	+$139	0.01%	304
2023 Q1	$33.6K	Sell	2,433 -37	-1%	-$545	0.01%	338
2022 Q4	$33K	Sell	2,470 -843	-25%	-$10.9K	0.01%	308
2022 Q3	$39K	Buy	3,313 +1,698	+105%	+$24.1K	0.02%	268
2022 Q2	$21K	Buy	1,615 +186	+13%	+$2.39K	0.01%	425
2022 Q1	$18K	Buy	1,429 +169	+13%	+$2.23K	0.01%	505
2021 Q4	$20K	Hold	1,260	–	–	0.01%	503
2021 Q3	$25K	Buy	1,260 +26	+2%	+$516	0.01%	402
2021 Q2	$28K	Hold	1,234	–	–	0.01%	380
2021 Q1	$23K	Hold	1,234	–	–	0.01%	517
2020 Q4	$18K	Sell	1,234 -24	-2%	-$313	0.01%	545
2020 Q3	$14K	Hold	1,258	–	–	0.01%	549
2020 Q2	$9K	Sell	1,258 -1,112	-47%	-$9.21K	﹤0.01%	672
2020 Q1	$19K	Sell	2,370 -156	-6%	-$1.85K	0.01%	381
2019 Q4	$31K	Sell	2,526 -113	-4%	-$1.22K	0.02%	336
2019 Q3	$23K	Buy	2,639 +221	+9%	+$1.93K	0.01%	416
2019 Q2	$20K	Sell	2,418 -934	-28%	-$7.38K	0.01%	474
2019 Q1	$25K	Sell	3,352 -653	-16%	-$5.25K	0.01%	516
2018 Q4	$33K	Sell	4,005 -138	-3%	-$1.32K	0.02%	355
2018 Q3	$41K	Sell	4,143 -5	-0.1%	-$52	0.02%	348
2018 Q2	$40K	Sell	4,148 -433	-9%	-$4.25K	0.02%	369
2018 Q1	$42K	Sell	4,581 -196	-4%	-$1.87K	0.02%	350
2017 Q4	$45K	Sell	4,777 -136	-3%	-$1.3K	0.02%	340
2017 Q3	$50K	Buy	4,913 +1,142	+30%	+$10.5K	0.03%	256
2017 Q2	$31K	Buy	3,771 +922	+32%	+$6.92K	0.02%	402
2017 Q1	$20K	Sell	2,849 -41	-1%	-$297	0.01%	589
2016 Q4	$20K	Buy	2,890 +509	+21%	+$3.54K	0.01%	594
2016 Q3	$17K	Sell	2,381 -282	-11%	-$1.79K	0.01%	628
2016 Q2	$15K	Buy	2,663 +87	+3%	+$576	0.01%	644
2016 Q1	$16K	Buy	2,576 +2,394	+1,315%	+$12.8K	0.01%	599
2015 Q4	$1K	Buy	+182	New	+$1.14K	﹤0.01%	1277

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Versant Capital Management's SEM Position: Q2 2026 in Review

Versant Capital Management held its Select Medical (SEM) position steady in Q2 2026 at 1,915 shares worth $31.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1684.

Versant Capital Management first reported a position in SEM in Q4 2015 and has held it in 43 quarters since. The position peaked at $50K in Q3 2017. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Versant Capital Management held 1,915 shares of Select Medical worth $31.6K as of Q2 2026.
Versant Capital Management left its Select Medical share count unchanged in Q2 2026.
Select Medical made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1684 holding.
Versant Capital Management first reported a position in Select Medical in Q4 2015 and has held it in 43 quarters since.
Versant Capital Management's Select Medical position peaked at $50K in Q3 2017.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.